Oncologic follow-up and surveillance after curative therapy for invasive breast cancer serves as a quality control of the primary treatment results, enables the early diagnosis and immediate treatment in case of recurrent disease, the detection and therapy of treatment-related side effects and late sequelae, and finally includes the psychologic support of tumor-free patients over decades, during which they are at risk for recurrent disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1024/0040-5930.65.6.319 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!